Who is sponsoring ReVERSE?

ReVERSE is sponsored by Rigshospitalet, Denmark.

What condition does ReVERSE study?

ReVERSE studies Right Ventricular Dysfunction.

What drugs are being tested in ReVERSE?

Interventions: Change in preload and afterload, Inspired oxygen, Pacemaker mode.

What is the status of ReVERSE?

ReVERSE is currently COMPLETED.

Last reviewed 2018-01-09 · How we verify

Right Ventricular Echocardiography in caRdiac SurgEry (ReVERSE)

NCT03301571 NA COMPLETED

Postoperative right ventricular (RV) dysfunction increases mortality and risk of cardiac failure after cardiac surgery substantially. A comprehensive understanding of this condition is paramount in order to achieve success in treatment and early diagnosis. This study has two main aims. Perioperative aim: To investigate correlations between changes in echocardiographic measurements and hemodynamic changes at baseline and following coronary artery bypass graft (CABG) surgery. Postoperative aim: To evaluate changes in haemodynamics and echocardiographic parameters during separate physiological interventions (increase in preload/afterload, oxygen fraction, pacing modes (AAI/DDD/VVI)).

Details

Lead sponsor	Rigshospitalet, Denmark
Phase	NA
Status	COMPLETED
Enrolment	30
Start date	Thu May 04 2017 00:00:00 GMT+0000 (Coordinated Universal Time)
Completion	Thu Oct 05 2017 00:00:00 GMT+0000 (Coordinated Universal Time)

Conditions

Right Ventricular Dysfunction

Interventions

Change in preload and afterload
Inspired oxygen
Pacemaker mode

Countries

Denmark